Targeting Huntingtin Expression in Patients with Huntington’s Disease
Authors:
- Sarah J. TabriziSTSarah J. Tabrizi
- Blair R. LeavittBLBlair R. Leavitt
- G. Bernhard LandwehrmeyerGLG. Bernhard Landwehrmeyer
- Edward J. WildEWEdward J. Wild
- Carsten SaftCSCarsten Saft
- Roger A. BarkerRBRoger A. Barker
- Nick F. BlairNBNick F. Blair
- David CraufurdDCDavid Craufurd
- Josef PrillerJPJosef Priller
- Hugh RickardsHRHugh Rickards
- Anne RosserARAnne Rosser
- Holly B. KordasiewiczHKHolly B. Kordasiewicz
Top Cited Papers
- 13 June 2019
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 380 (24) , 2307-2316
Abstract
Huntington’s disease is an autosomal-dominant neurodegenerative disease caused by CAG trinucleotide repeat expansion in HTT, resulting in a mutant huntingtin protein. IONIS-HTTRx (hereafter, HTTRx) is an antisense oligonucleotide designed to inhibit HTT messenger RNA and thereby reduce concentrations of mutant huntingtin.Keywords
Funding Information
- Ionis Pharmaceuticals
- F. Hoffmann-La Roche
This publication has 26 references indexed in Scilit:
- The Role of the Immune System in Huntington’s DiseaseJournal of Immunology Research, 2013
- Sustained Therapeutic Reversal of Huntington's Disease by Transient Repression of Huntingtin SynthesisNeuron, 2012
- Huntington's disease: from molecular pathogenesis to clinical treatmentThe Lancet Neurology, 2011
- RNA Targeting Therapeutics: Molecular Mechanisms of Antisense Oligonucleotides as a Therapeutic PlatformAnnual Review of Pharmacology and Toxicology, 2010
- Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosisNeurology, 2008
- CAG repeat number governs the development rate of pathology in Huntington's diseaseAnnals of Neurology, 1997
- The boundary shift integral: an accurate and robust measure of cerebral volume changes from registered repeat MRIIEEE Transactions on Medical Imaging, 1997
- Unified Huntington's disease rating scale: Reliability and consistencyMovement Disorders, 1996
- The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's diseaseNature Genetics, 1993
- A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomesCell, 1993